ArticleEmergency medicine Australasia : EMA2026
One-Year Reattendance Rates to the Emergency Department for Acute Illicit Drug Exposure in Western Australia: A Retrospective Registry Study.
Article in Emergency medicine Australasia : EMA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveDetermine 1-year emergency department (ED) drug-related reattendance rates of patients enrolled in the Emerging Drugs Network of Australia across five Western Australian hospitals.
methodsIndex presentations and 1-year reattendances were extracted. Reattendance rates were calculated and stratified by confirmed novel or traditional illicit drugs.
resultsOf 1141 patients, 5.0% (95% CI: 3.9%-6.4%) reattended the ED for drug exposure within 1 year. No statistical differences between novel and traditional illicit drugs were identified.
conclusionA conservative but discernible reattendance rate with confirmed illicit drug exposure was demonstrated. Objective data can inform hospital-based harm reduction services and reduce future drug exposure risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.